[{"address1": "628 Middlefield Road", "city": "Palo Alto", "state": "CA", "zip": "94301", "country": "United States", "website": "https://kalaristx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kalaris Therapeutics, Inc., a clinical-stage ophthalmology biotech company, engages in developing therapies for the treatment of neovascular retinal diseases. Kalaris Therapeutics, Inc. was formerly known as Theia Therapeutics, Inc. and changed its name to Kalaris Therapeutics, Inc. in May 2024. The company was incorporated in 2019 and is based in Palo Alto, California.", "fullTimeEmployees": 14, "companyOfficers": [{"maxAge": 1, "name": "Mr. Andrew  Oxtoby", "age": 50, "title": "President, CEO & Director", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 660130, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Srinivas  Akkaraju M.D., Ph.D.", "age": 56, "title": "Director & Co-Founder", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael Philip Dybbs Ph.D.", "age": 49, "title": "Director & Co-Founder", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Napoleone  Ferrara M.D.", "age": 67, "title": "Independent Director & Co-Founder", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew  Gall M.B.A.", "age": 48, "title": "CFO & Treasurer", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brett R. Hagen", "age": 51, "title": "Chief Accounting Officer", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew  Feinsod M.D.", "age": 53, "title": "Chief Medical Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kristine  Curtiss", "title": "Senior Vice President of Clinical", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.9, "open": 6.91, "dayLow": 6.04, "dayHigh": 7.07, "regularMarketPreviousClose": 6.9, "regularMarketOpen": 6.91, "regularMarketDayLow": 6.04, "regularMarketDayHigh": 7.07, "payoutRatio": 0.0, "volume": 198481, "regularMarketVolume": 198481, "averageVolume": 359985, "averageVolume10days": 198540, "averageDailyVolume10Day": 198540, "bid": 5.08, "ask": 8.08, "bidSize": 2, "askSize": 2, "marketCap": 131103952, "fiftyTwoWeekLow": 2.14, "fiftyTwoWeekHigh": 13.179, "allTimeHigh": 1126.08, "allTimeLow": 2.14, "fiftyDayAverage": 5.2207, "twoHundredDayAverage": 5.258205, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 55649952, "forwardPE": -2.951579, "profitMargins": 0.0, "floatShares": 4627165, "sharesOutstanding": 18702418, "sharesShort": 403085, "sharesShortPriorMonth": 681273, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.0216, "heldPercentInsiders": 0.12592, "heldPercentInstitutions": 0.70817, "shortRatio": 2.26, "shortPercentOfFloat": 0.0851, "impliedSharesOutstanding": 18702418, "bookValue": 2.238, "priceToBook": 3.1322613, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -55466000, "trailingEps": -38.05, "lastSplitFactor": "1:23", "lastSplitDate": 1736985600, "52WeekChange": -0.45454544, "SandP52WeekChange": 0.09209216, "quoteType": "EQUITY", "currentPrice": 7.01, "targetHighPrice": 23.0, "targetLowPrice": 5.0, "targetMeanPrice": 17.8, "targetMedianPrice": 20.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 76999000, "totalCashPerShare": 4.117, "totalDebt": 1545000, "quickRatio": 12.696, "currentRatio": 12.891, "debtToEquity": 3.69, "returnOnAssets": -0.63495, "freeCashflow": -12817250, "operatingCashflow": -39164000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "KLRS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 359985, "fiftyTwoWeekLowChange": 4.87, "fiftyTwoWeekLowChangePercent": 2.2757008, "fiftyTwoWeekRange": "2.14 - 13.179", "fiftyTwoWeekHighChange": -6.1689997, "fiftyTwoWeekHighChangePercent": -0.46809316, "fiftyTwoWeekChangePercent": -45.454544, "earningsTimestampStart": 1754569800, "earningsTimestampEnd": 1754569800, "isEarningsDateEstimate": true, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1596115800000, "postMarketChangePercent": 0.0, "postMarketPrice": 7.01, "postMarketChange": 0.0, "regularMarketChange": 0.11, "regularMarketDayRange": "6.04 - 7.07", "regularMarketChangePercent": 1.5942, "regularMarketPrice": 7.01, "shortName": "Kalaris Therapeutics, Inc.", "longName": "Kalaris Therapeutics, Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1763760000, "regularMarketTime": 1763758802, "exchange": "NGM", "messageBoardId": "finmb_1900954228", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "epsTrailingTwelveMonths": -38.05, "epsCurrentYear": -3.7, "priceEpsCurrentYear": -1.8945947, "fiftyDayAverageChange": 1.7893004, "fiftyDayAverageChangePercent": 0.34273192, "twoHundredDayAverageChange": 1.7517953, "twoHundredDayAverageChangePercent": 0.33315462, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "displayName": "Kalaris Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-22"}]